Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival - Concepedia

Concepedia

Publication | Closed Access

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

57

Citations

29

References

2004

Year

R. Lamba, Esteban Abella, Debra Kukuruga, JL Klein, Süreyya Savaşan, Muneer H. Abidi, A. Mohamed, E. Peres

Cell TherapyTransplantationMarrow TransplantationDay 90Bone Marrow FailureMixed Hematopoietic ChimerismStem Cell TransplantationHematologyImmunologyStem Cell ResearchMedicineCell Transplantation

References

	Year	Citations

Page 1

Page 1